Back to Report Store Home

Emerging Market for Clinical Trials in Russia - Curbs on New Drug Approval Timelines and Registration Fees Encourage the Emergence of a Major Global Player

  • Published: Jul-2011
  • Report Code: GBIHC102MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Clinical Trials in Russia, Segmentation of Clinical Trials by Study Type, Russia (%), 2005-2010 (Jan –June)

Figure 2: Clinical Trials in Russia, Number of Clinical Trials by Study Type, Russia, 2005-2010 (Jan-June)

Figure 3: Clinical Trials in Russia, Major Countries Sponsoring Clinical Trials, Russia, 2008-2010 (Jan –June)

Figure 4: Clinical Trials in Russia, Clinical Trials Sponsored by Major Countries (%), Russia, 2009

Figure 5: Clinical Trials in Russia, Number of Clinical Trials Initiated by Major Companies, Russia, 2009

Figure 6: Clinical Trials in Russia, Number of Clinical Trials Initiated by Indication (%),

Russia, 2009

Figure 7: Clinical Trials in Russia, Number of Clinical Trials by Study Type, Russia, 2005-2010 (Jan-June)

Figure 8: Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2010 (Jan-June)

Figure 9: Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2009

Figure 10: Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2008

Figure 11: Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2007

Figure 12 Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2006

Figure 13: Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2005

Figure 14: Clinical Trials in Russia, Number of Clinical Trials by Study Type (%), Russia, 2004

Figure 15: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase, Russia, 2005-2010 (Jan-June)

Figure 16: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase (%), Russia, 2009

Figure 17: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase (%), Russia, 2008

Figure 18: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase (%), Russia, 2007

Figure 19: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase (%), Russia, 2006

Figure 20: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase (%), Russia, 2005

Figure 21: Clinical Trials in Russia, Type of Foreign Sponsored Clinical Trials by Phase (%), Russia, 2004

Figure 22: Clinical Trials in Russia, Number of International Multicenter Clinical Trials Conducted in Russia, 2004-2009

Figure 23: Clinical Trials in Russia, Number of Local Clinical Trials Conducted by Local Sponsors, Russia, 2004-2009

Figure 24: Clinical Trials in Russia, Number of Bioequivalence Studies Conducted by Local Sponsors, Russia, 2004-2009

Figure 25: Clinical Trials in Russia, Number of Local Clinical Trials Conducted by Foreign Sponsors, Russia, 2004-2009

Figure 26: Clinical Trials in Russia, Number of Approved Foreign Sponsored Clinical Trials, Russia, 2004-2010 (Jan-June)

Figure 27: Clinical Trials in Russia, Global BLA and NME Approvals vs. R&D Spending, ($bn), 1995-2009

Figure 28: Clinical Trials in Russia, Activities of R&D Restructuring, 2010

Figure 29: Clinical Trials in Russia, Number of Phase l Clinical Trials Registered, Russia,

2005-2010

Figure 30: Clinical Trials in Russia, Number of Phase Il Clinical Trials Registered, Russia,

2005-2010

Figure 31: Clinical Trials in Russia, Number of Phase IlI Clinical Trials Registered, Russia,

2005-2010

Figure 32: Clinical Trials in Russia, Number of Phase IV Clinical Trials Registered, Russia,

2005-2010

Figure 33: Clinical Trials in Russia, Number of Clinical Trials Registered by Phase (%), Russia, 2010

Figure 34: Clinical Trials in Russia, CRO Market, Russia, ($m), 2009-2017

Figure 35: Clinical Trials in Russia, Number of Patients Recruited for Clinical Trials, Russia,

2004-2008

Figure 36: Clinical Trials in Russia, Population, Russia, (million), 2004-2010

Figure 37: Clinical Trials in Russia, Population, Russia, (million), 2004-2010

Figure 38: Clinical Trials in Russia, Population Forecast for HIV (million), Russia, 2009-2015

Figure 39: Clinical Trials in Russia, Population Forecast for Cancer (thousand), Russia, 2009-2015

Figure 40: Clinical Trials in Russia, Population Forecast for Diabetes (million), Russia, 2009-2015

Figure 41: Clinical Trials in Russia, Forecast for Tuberculosis Incidence per 100,000, Russia,

2009-2015

Figure 42:Clinical Trials in Russia, Mortality due to Major Diseases, Russia, 2004-2009

Figure 43: Clinical Trials in Russia, Total Number of Deaths per 100,000 People, Russia,

2004-2009

Figure 44: Clinical Trials in Russia, Number of Deaths due to Circulatory Diseases

(per 100,000 People), Russia, 2004-2009

Figure 45: Clinical Trials in Russia, Number of Deaths due to Respiratory Diseases

(per 100,000 People), Russia, 2004-2009

Figure 46: Clinical Trials in Russia, Number of Deaths due to Digestive Diseases

(per 100,000 People), Russia, 2004-2009

Figure 47: Clinical Trials in Russia, Number of Deaths due to Infections and Parasitic Diseases (per 100,000 People), Russia, 2004-2009

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards